Antiphospholipid Syndrome

Shamik Bhattacharyya; Tracey A Cho

doi:10.1007/978-3-030-16928-2_5

Back

Book chapter

Antiphospholipid Syndrome

Shamik Bhattacharyya and Tracey A Cho

Neurorheumatology, pp.45-49

Springer International Publishing

06/30/2019

DOI: 10.1007/978-3-030-16928-2_5

View Online

Abstract

Antiphospholipid syndrome (APS) is an acquired thrombotic syndrome characterized by arterial/venous thrombosis and pregnancy complications and by the presence of antiphospholipid antibodies. The pathogenesis is complex and mediated not only by the antibodies but also by thrombotic initiation events. It occurs either as a primary disease or in the context of other autoimmune diseases such as systemic lupus erythematosus (SLE). The most widely accepted classification criteria is the revised Sapporo criteria (also known as Sydney criteria).

Thrombocytopenia

Catastrophic APS

Antiphospholipid syndrome (APS)

Pregnancy morbidity

Seronegative APS

Revised Sapporo criteria

Thrombosis

Renal microangiopathy

Details

Title: Subtitle: Antiphospholipid Syndrome
Creators: Shamik Bhattacharyya - Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA
Tracey A Cho - Division of Neuroimmunology, University of Iowa, Iowa City, USA
Resource Type: Book chapter
Publication Details: Neurorheumatology, pp.45-49
DOI: 10.1007/978-3-030-16928-2_5
Publisher: Springer International Publishing; Cham
Language: English
Date published: 06/30/2019
Academic Unit: Neurology; Iowa Neuroscience Institute
Record Identifier: 9984071724902771

Metrics

33 Record Views